Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium

AAPS PharmSciTech

Volumn 4, Issue 3, 2003, Pages

  Al Taani, Bashar M ^a   Tashtoush, Bassam M ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Buffered matrix; Controlled release; Erosion; Sustained release; Swelling

Indexed keywords

BUFFER; DICLOFENAC; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; PHOSPHATE;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; IONIC STRENGTH; LINEAR REGRESSION ANALYSIS; MATHEMATICAL COMPUTING; MICROENVIRONMENT; MOLECULAR WEIGHT; PH; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET MATRIX; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 23144434001     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040343     Document Type: Article

References (25)

1. Chien YW. Fundamentals of rate-controlled drug delivery; In: Novel Drug Delivery Systems. 2nd ed. New York, NY: Marcel Dekkar; 1992: 43-137
2. Gao P, Meury RH. Swelling hydroxypropyl methylcelloluse matrix tablets. 1. Characterization of swelling using a novel optical imaging method. J Pharm Sci. 1996;85(7):725-731.
3. Ammar HO, Khalil RM. Preparation and evaluation of sustained-release solid dispersions of drugs with Eudragit polymers. Drug Dev Ind Pharm. 1997;23(11):1043-1054.
4. Kislalioglu MS, Khan MA, Blount C, Goettch RW, Bolton S. Physical characterization and dissolution properties of ibuprofen: eudragit coprecipitates. J Pharm Sci. 1991;80:799-804.
5. Wade A, Weller PJ, eds. Handbook of Pharmaceutical Excipients. London, UK: Pharmaceutical Press; 1994:362-366.
6. Bainchini R, Resciniti M, Vecchio C. Technological evaluation of aqueous enteric coated systems with and without insoluble additives. Drug Dev Ind Pharm. 1991;17:1779-1794.
7. Durig T, Venkatesh GM, Fassihi R. An investigation into the erosion behavior of high drug-load (85%) particulate system designed for an extended-release matrix tablet: analysis of erosion kinetics in conjunction with variation in lubrication, porosity, and compaction rate. J Pharm Pharmacol. 1999;51:1085-1092.
8. Mehta KA, Kislalioglu MS, Phuapradit W, Malick AW, Shah NH. Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix. Int J Pharm. 2001;213:7-12.
9. Khan MZI, Stedul HP, Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations. Drug Dev Ind Pharm. 2000;26(5):549-554.
10. Terao T, Matsuda K, Shougi H. Improvement in site specific intestinal absorption of furocemide by Eudragit L100-55. J Pharm Pharmacol. 2001;53:433-440.
11. Lee PI. Diffusional release of a solute from a polymeric matrix-approximate analytical solutions. J Memb Sci. 1980;7:255-275.
12. Blase CM, Peck GE. Development of a unique buffered matrix aspirin tablet. Drug Dev Ind Pharm. 1992;18(8):869-893.
13. Finne U, Vaisanen V, Urtti A. Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictor. Int J Pharm. 1990;65:19-27.
14. Martin A, Bustamante P, Chun A, eds. Buffered and isotonic solutions; In: Physical Pharmacy. 4th ed. Philadelphia, PA: Lea & Febiger; 1993: 169-189.
15. Abrahamsson B, Alpesten M, Bake B, Larsson A, Sjogren J. In vitro and in vivo erosion of two different hydrophilic gel matrix tablets. Eur J Pharm Biopharm. 1998;46:69-75.
16. Sheu M, Chou H, Kao C, Liu C, Sokoloski T. Dissolution of diclofenac sodium from matrix tablet. Int J Pharm. 1992;85:57-63.
17. Carelli V, Di Colo G, Nannipieri E, Poli B, Serafini MF. Poly(oxyethylene)-Poly(methacrylic acid-co-methyl methacrylate) compounds for site specific per oral delivery. Int J Pharm. 2000;202:103-112.
18. Bettini R, Colombo P, Peppas NA. Solubility effects on drug transport through pH sensitive swelling-controlled release system: transport of theophylline and metaclopramide monohydrochloride. J Control Release. 1995;37:150-111.
19. Kim CJ, Lee PI. Hydrophobic anionic gel beads for swelling-controlled drug delivery. Pharm Res. 1992;9:195-199.
20. Kim C. Application of shrinking-core model for ionization of hydrophobic ionic beads. Drug Dev Ind Pharm. 1996:22;307-311.
21. Cameron CG, McGinity JW. Controlled release theophylline tablet formulations containing acrylic resins. Part 2. Combination resin formulations. Drug Dev Ind Pharm. 1987;13(8):1409-1427.
22. Avdeef A, Berger CM, Brownell C. pH-metric solubility. 2. Correlation between the acid-base titration and the saturation shake-flask solubility pH methods. Pharm Res. 2000;17:85-89.
23. Sarjeev C, Saha RN. Formulation and comparative evaluation of controlled release diclofenac tablets prepared by matrix-embedding technique, membrane barrier technique, and combination of the two. Drug Dev Res. 2001;53:1-8.
24. Padmalatha DK, Ranga Rao KV, Baveja S, Fathi M, Roth M. Zero-order release formulation of oxprenolol hydrochloride with swelling and erosion control. Pharm Res. 1989;6:313-317.
25. Efentakis M, Koutlis A. Release of furosemide from multiple unit and single unit preparations containing different viscosity grades of sodium alginate. Pharm Dev Tech. 2001;6(1):91-98.